Cargando…
Next-Generation Sequencing Reveals the Role of Epigallocatechin-3-Gallate in Regulating Putative Novel and Known microRNAs Which Target the MAPK Pathway in Non-Small-Cell Lung Cancer A549 Cells
Lung cancer constitutes 85% of non-small cell lung cancer diagnosed cases. MicroRNAs are novel biomarkers that are capable of modulating multiple oncogenic pathways. Epigallocatechin-3-gallate (EGCG) is a potent chemopreventive and chemotherapeutic agent for cancer. We aimed to identify important kn...
Autores principales: | Bhardwaj, Vaishali, Mandal, Abul Kalam Azad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359307/ https://www.ncbi.nlm.nih.gov/pubmed/30669618 http://dx.doi.org/10.3390/molecules24020368 |
Ejemplares similares
-
Role of epigallocatechin-3- gallate in the regulation of known and novel microRNAs in breast carcinoma cells
por: Banerjee, Shrila, et al.
Publicado: (2022) -
Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)
por: Singh, Neha Atulkumar, et al.
Publicado: (2016) -
Epigallocatechin-3-Gallate Enhances the Therapeutic Effects of Leptomycin B on Human Lung Cancer A549 Cells
por: Cromie, Meghan M., et al.
Publicado: (2015) -
The protective role of (−)-epigallocatechin-3-gallate in thrombin-induced neuronal cell apoptosis and JNK-MAPK activation
por: He, Qianqian, et al.
Publicado: (2015) -
Effects of (-)-epigallocatechin gallate on RPE cell migration and adhesion
por: Chan, Chi-Ming, et al.
Publicado: (2010)